These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 23318263)

  • 1. Liver cancer: Intrahepatic cholangiocarcinoma--appearances can be deceiving.
    Alison MR; Lin WR
    Nat Rev Gastroenterol Hepatol; 2013 Mar; 10(3):131-3. PubMed ID: 23318263
    [No Abstract]   [Full Text] [Related]  

  • 2. Mixed hepatocellular-cholangiocarcinoma may derive from "hepatogones".
    Hunt JP; Varnholt H
    Hepatobiliary Pancreat Dis Int; 2008 Feb; 7(1):105; author reply 105-6. PubMed ID: 18234649
    [No Abstract]   [Full Text] [Related]  

  • 3. Cell lineage tracing reveals a biliary origin of intrahepatic cholangiocarcinoma.
    Guest RV; Boulter L; Kendall TJ; Minnis-Lyons SE; Walker R; Wigmore SJ; Sansom OJ; Forbes SJ
    Cancer Res; 2014 Feb; 74(4):1005-10. PubMed ID: 24310400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of differentiation of intrahepatic cholangiocarcinoma cells to functional hepatocytes using an organoid culture system.
    Saito Y; Nakaoka T; Muramatsu T; Ojima H; Sukeda A; Sugiyama Y; Uchida R; Furukawa R; Kitahara A; Sato T; Kanai Y; Saito H
    Sci Rep; 2018 Feb; 8(1):2821. PubMed ID: 29434290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver stem cells and their implication in hepatocellular and cholangiocarcinoma.
    Roskams T
    Oncogene; 2006 Jun; 25(27):3818-22. PubMed ID: 16799623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrahepatic cholangiocarcinoma can arise from Notch-mediated conversion of hepatocytes.
    Sekiya S; Suzuki A
    J Clin Invest; 2012 Nov; 122(11):3914-8. PubMed ID: 23023701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocellular cancer, cholangiocarcinoma, and metastatic tumors of the liver.
    Wagman LD
    Surg Oncol Clin N Am; 2015 Jan; 24(1):xiii-xiv. PubMed ID: 25444478
    [No Abstract]   [Full Text] [Related]  

  • 8. Hepatocellular cancer, cholangiocarcinoma, and metastatic tumors of the liver.
    Petrelli NJ
    Surg Oncol Clin N Am; 2015 Jan; 24(1):xi-xii. PubMed ID: 25444477
    [No Abstract]   [Full Text] [Related]  

  • 9. A case of an alpha-fetoprotein-producing intrahepatic cholangiocarcinoma suggests probable cancer stem cell origin.
    Ishikawa K; Sasaki A; Haraguchi N; Yoshikawa Y; Mori M
    Oncologist; 2007 Mar; 12(3):320-4. PubMed ID: 17405896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver Cancer Cell of Origin, Molecular Class, and Effects on Patient Prognosis.
    Sia D; Villanueva A; Friedman SL; Llovet JM
    Gastroenterology; 2017 Mar; 152(4):745-761. PubMed ID: 28043904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The roles of transforming growth factor-β, Wnt, Notch and hypoxia on liver progenitor cells in primary liver tumours (Review).
    Bogaerts E; Heindryckx F; Vandewynckel YP; Van Grunsven LA; Van Vlierberghe H
    Int J Oncol; 2014 Apr; 44(4):1015-22. PubMed ID: 24504124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Stem cell and cancer in bile epithelial cells].
    Taniguchi H; Chiba T
    Nihon Rinsho; 2006 Jan; 64 Suppl 1():348-53. PubMed ID: 16457280
    [No Abstract]   [Full Text] [Related]  

  • 13. Identification of hepatic stem/progenitor cells in canine hepatocellular and cholangiocellular carcinoma.
    Cogliati B; Aloia TP; Bosch RV; Alves VA; Hernandez-Blazquez FJ; Dagli ML
    Vet Comp Oncol; 2010 Jun; 8(2):112-21. PubMed ID: 20579324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protocol for the examination of specimens from patients with hepatocellular carcinoma and cholangiocarcinoma, including intrahepatic bile ducts. Cancer Committee of the College of American Pathologists.
    Ruby SG
    Arch Pathol Lab Med; 2000 Jan; 124(1):41-5. PubMed ID: 10629130
    [No Abstract]   [Full Text] [Related]  

  • 15. [Case 6: Combined hepatocellular and cholangiocarcinoma].
    Bedossa P
    Ann Pathol; 2007 Apr; 27(2):112-4. PubMed ID: 17909467
    [No Abstract]   [Full Text] [Related]  

  • 16. [Tumor grading of the hepatobiliary system].
    Jütte H; Tannapfel A
    Pathologe; 2016 Jul; 37(4):299-303. PubMed ID: 27342594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic utility of GLUT1 in the differential diagnosis of liver carcinomas.
    Roh MS; Jeong JS; Kim YH; Kim MC; Hong SH
    Hepatogastroenterology; 2004; 51(59):1315-8. PubMed ID: 15362741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Gallbladder and bile duct carcinoma. Biology and pathology].
    Tannapfel A; Wittekind C
    Internist (Berl); 2004 Jan; 45(1):33-41. PubMed ID: 14735242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intrahepatic sarcomatoid cholangiocarcinoma with osteoclast-like giant cells: report of a case].
    Fan XS; Chen J; Wu HY; Qiu YD; Zhang WW; Kong WT
    Zhonghua Bing Li Xue Za Zhi; 2010 Sep; 39(9):640-1. PubMed ID: 21092600
    [No Abstract]   [Full Text] [Related]  

  • 20. Cocarcinogenic effects of intrahepatic bile acid accumulation in cholangiocarcinoma development.
    Lozano E; Sanchez-Vicente L; Monte MJ; Herraez E; Briz O; Banales JM; Marin JJ; Macias RI
    Mol Cancer Res; 2014 Jan; 12(1):91-100. PubMed ID: 24255171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.